logo-loader
viewOzop Surgical Corp.

Ozop Surgical completes initial testing of its adjustable ALIF interbody spinal implant

CEO Michael Chermak says company encouraged by initial testing results and has 'incorporated several improvements into our next design'

spine
The implant allows a surgeon to expand it after insertion into a disc space, reducing operating times

Ozop Surgical Corp. (OTCMKTS:OZSC) announced Monday it has completed initial testing of its adjustable ALIF interbody spinal implant.

The Florida-based company began development of the ALIF implant, which is short for enhanced expandable anterior lumbar interbody fusion, in 2018.

The ALIF implant allows the surgeon to expand it after insertion into a disc space, reducing operating times while providing a cost savings for the hospital.

READ: Ozop rises as company gives vision for minimally invasive spinal surgery

CEO Michael Chermak said the company is encouraged by the initial-testing results and has “incorporated several improvements into our next design.”

Once the testing is completed and a final designated accepted, Ozop plans to submit the final design to the US Food and Drug Administration within the next two years. 

“Developing an infinitely adjustable ALIF implant is a challenging design goal but the end outcome will allow the surgeon to ensure segmental stability and restore sagittal balance,” Chermak said. “We look forward to completing testing for FDA submission in the near future and hope to have our approval by the end of the year."

Ozop’s stock trades around $0.045 a share.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Ozop Surgical Corp.

Price: 0.0105 USD

OTCMKTS:OZSC
Market: OTCMKTS
Market Cap: $838.58 k
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ozop Surgical Corp. named herein, including the promotion by the Company of Ozop Surgical Corp. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OZOP Surgical makes headway on bringing its spine implant tech to market

OZOP Surgical Corp (OTCQB:OZSC) COO Thomas McLeer tells Proactive Investors the medical device company is making headway with its surgical implant devices. McLeer says over the next year the Florida based company is developing the first percutaneous spinal fusion implant system to allow...

on 01/15/2019

2 min read